Intetumumab (CNTO 95) is a glycoengineered anti-EGFR monoclonal antibody designed to enhance antibody-dependent cellular cytotoxicity (ADCC). This potent therapeutic tool is specifically utilized in cancer research to investigate the mechanisms of tumor cell inhibition mediated by EGFR targeting.
Intetumumab (CNTO 95) is a glycoengineered anti-EGFR monoclonal antibody designed to enhance antibody-dependent cellular cytotoxicity (ADCC). This potent therapeutic tool is specifically utilized in cancer research to investigate the mechanisms of tumor cell inhibition mediated by EGFR targeting.
This calculator helps you calculate mass of compound based on solution concentration, volume and molecular weight in a specific solution using the formula:
